Dag Sehlin, PhD
Primary tabs
JAD profile
Affiliation(s):
Uppsala University
ORCID URL:
Areas of Interest:
anti-Aβ antibodies, immunotherapy, brain drug delivery, blood-brain barrier, immunoPET
Biography & Research:
- PhD at Uppsala university, Sweden, developing the original version of Aβ antibody lecanemab.
- Post doc and researcher, Uppsala university, developing receptor mediated delivery of antibodies across the BBB.
- Currently Professor of Molecular geriatrics, Uppsala University, engineering and using brain penetrating bispecific antibodies for therapy and immunoPET imaging of Aβ and other targets in the brain
